Drug-resistant influenza viruses: Why fitness matters

Nature Medicine

Volumn 18, Issue 10, 2012, Pages 1470-1471

  Kelso, Anne ^a   Hurt, Aeron C ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FAVIPIRAVIR; LANINAMIVIR; NITAZOXANIDE; OSELTAMIVIR; PERAMIVIR; VIRUS SIALIDASE; ZANAMIVIR; ANTIVIRUS AGENT;

2009 H1N1 INFLUENZA; AMINO ACID SUBSTITUTION; ANTIVIRAL RESISTANCE; CLINICAL TRIAL (TOPIC); ENZYME ACTIVE SITE; HUMAN; IMMUNOCOMPROMISED PATIENT; INFECTION PREVENTION; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; NONHUMAN; PRIORITY JOURNAL; SENTINEL SURVEILLANCE; SHORT SURVEY; VIRUS REPLICATION; VIRUS TRANSMISSION; ARTICLE; DRUG EFFECT; GENETICS; INFLUENZA; PATHOGENICITY; REPRODUCTIVE FITNESS; VIROLOGY;

ORTHOMYXOVIRIDAE;

ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; GENETIC FITNESS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; OSELTAMIVIR; ZANAMIVIR;

EID: 84870285674     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2954     Document Type: Short Survey

References (14)

1. Meijer, A. et al. Emerg. Infect. Dis. 15, 552-560 (2009).
2. Hurt, A.C. et al. Antiviral Res. 83, 90-93 (2009).
3. Moscona, A. N. Engl. J. Med. 353, 1363-1373 (2005).
4. Ives, J.A.L. et al. Antiviral Res. 55, 307-317 (2002).
5. Herlocher, M.L. et al. J. Infect. Dis. 190, 1627-1630 (2004).
6. Bloom, J.D., Gong, L.I. & Baltimore, D. Science 328, 1272-1275 (2010).
7. Rameix-Welti, M.A., Enouf, V., Cuvelier, F., Jeannin, P. & van der Werf, S. PLoS Pathog. 4, e1000103 (2008).
8. Hurt, A.C. et al. N. Engl. J. Med. 365, 2541-2542 (2011).
9. Storms, A.D. et al. Emerg. Infect. Dis. 18, 308-311 (2012).
10. Lackenby, A. et al. Euro Surveill. 16, 19784 (2011).
11. Hurt, A.C. et al. J. Infect. Dis. 206, 148-157 (2012).
12. Bloom, J.D., Nayak, J.S. & Baltimore, D. PLoS One 6, e22201 (2011).
13. Ison, M.G. Curr. Opin. Virol. 1, 563-573 (2011).
14. Vijaykrishna, D. et al. Science 328, 1529 (2010).